Cargando…

Type IA Topoisomerases as Targets for Infectious Disease Treatments

Infectious diseases are one of the main causes of death all over the world, with antimicrobial resistance presenting a great challenge. New antibiotics need to be developed to provide therapeutic treatment options, requiring novel drug targets to be identified and pursued. DNA topoisomerases control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seddek, Ahmed, Annamalai, Thirunavukkarasu, Tse-Dinh, Yuk-Ching
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823277/ https://www.ncbi.nlm.nih.gov/pubmed/33401386 http://dx.doi.org/10.3390/microorganisms9010086

Ejemplares similares

Inhibition of Zn(II) Binding Type IA Topoisomerases by Organomercury Compounds and Hg(II)
por: Cheng, Bokun, et al.
Publicado: (2015)

Mechanism of Type IA Topoisomerases
por: Dasgupta, Tumpa, et al.
Publicado: (2020)

The interaction between transport-segment DNA and topoisomerase IA—crystal structure of MtbTOP1 in complex with both G- and T-segments
por: Ferdous, Shomita, et al.
Publicado: (2022)

Direct Observation of Topoisomerase IA Gate Dynamics
por: Mills, Maria, et al.
Publicado: (2018)

Microbial Type IA Topoisomerase C-Terminal Domain Sequence Motifs, Distribution and Combination
por: Diaz, Brenda, et al.
Publicado: (2022)

Microheterogeneity of Topoisomerase IA/IB and Their DNA-Bound States
por: Jeanne Dit Fouque, Kevin, et al.
Publicado: (2019)

Analysis of DNA relaxation and cleavage activities of recombinant Mycobacterium tuberculosis DNA topoisomerase I from a new expression and purification protocol
por: Annamalai, Thirunavukkarasu, et al.
Publicado: (2009)

Investigating mycobacterial topoisomerase I mechanism from the analysis of metal and DNA substrate interactions at the active site
por: Cao, Nan, et al.
Publicado: (2018)

Mechanistic insights from structure of Mycobacterium smegmatis topoisomerase I with ssDNA bound to both N- and C-terminal domains
por: Cao, Nan, et al.
Publicado: (2020)

Bacterial topoisomerase I as a target for discovery of antibacterial compounds
por: Tse-Dinh, Yuk-Ching
Publicado: (2009)

Identification of Anziaic Acid, a Lichen Depside from Hypotrachyna sp., as a New Topoisomerase Poison Inhibitor
por: Cheng, Bokun, et al.
Publicado: (2013)

Localization of Mycobacterium tuberculosis topoisomerase I C-terminal sequence motif required for inhibition by endogenous toxin MazF4
por: Garcia, Pamela K., et al.
Publicado: (2022)

The role of the Zn(II) binding domain in the mechanism of E. coli DNA topoisomerase I
por: Ahumada, Adriana, et al.
Publicado: (2002)

Residues of E. coli topoisomerase I conserved for interaction with a specific cytosine base to facilitate DNA cleavage
por: Narula, Gagandeep, et al.
Publicado: (2012)

Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays
por: Sandhaus, Shayna, et al.
Publicado: (2018)

Deacetylation of topoisomerase I is an important physiological function of E. coli CobB
por: Zhou, Qingxuan, et al.
Publicado: (2017)

Resistance to topoisomerase cleavage complex induced lethality in Escherichia coli via titration of transcription regulators PurR and FNR
por: Liu, I-Fen, et al.
Publicado: (2011)

Structural basis for suppression of hypernegative DNA supercoiling by E. coli topoisomerase I
por: Tan, Kemin, et al.
Publicado: (2015)

Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound
por: Garcia, Pamela K., et al.
Publicado: (2019)

Biochemical Basis of E. coli Topoisomerase I Relaxation Activity Reduction by Nonenzymatic Lysine Acetylation
por: Zhou, Qingxuan, et al.
Publicado: (2018)

Mutation adjacent to the active site tyrosine can enhance DNA cleavage and cell killing by the TOPRIM Gly to Ser mutant of bacterial topoisomerase I
por: Cheng, Bokun, et al.
Publicado: (2008)

A diverse global fungal library for drug discovery
por: Niu, Guodong, et al.
Publicado: (2020)

Kinetic Study of DNA Topoisomerases by Supercoiling-Dependent Fluorescence Quenching
por: Wang, Yunke, et al.
Publicado: (2019)

Multiple-attempt dynamics of type IA topoisomerases revealed in an orthogonal single-molecule experiment
por: Gunn, Kathryn H., et al.
Publicado: (2017)

Experimental and computational investigations of Ser10 and Lys13 in the binding and cleavage of DNA substrates by Escherichia coli DNA topoisomerase I
por: Strahs, Daniel, et al.
Publicado: (2006)

What’s on the Other Side of the Gate: A Structural Perspective on DNA Gate Opening of Type IA and IIA DNA Topoisomerases
por: Vidmar, Vita, et al.
Publicado: (2023)

A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases
por: Schmidt, Bryan H., et al.
Publicado: (2010)

Inhibition of Mg(2+) binding and DNA religation by bacterial topoisomerase I via introduction of an additional positive charge into the active site region
por: Sorokin, Elena P., et al.
Publicado: (2008)

The DNA relaxation activity and covalent complex accumulation of Mycobacterium tuberculosis topoisomerase I can be assayed in Escherichia coli: application for identification of potential FRET-dye labeling sites
por: Narula, Gagandeep, et al.
Publicado: (2010)

Identification of a Functional Type IA Topoisomerase, LdTopIIIβ, from Kinetoplastid Parasite Leishmania donovani
por: Banerjee, Bijoylaxmi, et al.
Publicado: (2011)

Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents
por: Wang, Wenjie, et al.
Publicado: (2019)

Topoisomerase I in Human Disease Pathogenesis and Treatments
por: Li, Min, et al.
Publicado: (2016)

Unraveling topoisomerase IA gate dynamics in presence of PPEF and its preclinical evaluation against multidrug-resistant pathogens
por: Maurya, Vikas, et al.
Publicado: (2023)

RNA topoisomerase is prevalent in all domains of life and associates with polyribosomes in animals
por: Ahmad, Muzammil, et al.
Publicado: (2016)

Recent developments in topoisomerase-targeted cancer chemotherapy
por: Hevener, KirkE., et al.
Publicado: (2018)

Targeting DNA Topoisomerase II in Antifungal Chemotherapy
por: Kondaka, Kavya, et al.
Publicado: (2022)

On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
por: Wu, Chyuan-Chuan, et al.
Publicado: (2013)

PPARG as therapeutic target for antifibrotic therapy
por: Ghallab, Ahmed, et al.
Publicado: (2020)

DNA topoisomerases as molecular targets for anticancer drugs
por: Buzun, Kamila, et al.
Publicado: (2020)

Autophagy and bacterial infectious diseases
por: Yuk, Jae-Min, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8064vctqru85867pm6gijnkhuq